Research Article

Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers

Figure 5

Serum GOLPH3 concentrations were detected in GC and CRC patients before and after radical surgery. The Wilcoxon test was used to analyze the difference of serum GOLPH3 concentration. (a) Concentrations of serum GOLPH3 in GC patients at 1 month after surgery were significantly lower than those before and at 1 week after surgery (). (b) Concentrations of serum GOLPH3 in CRC patients at 1 week and 1 month after surgery were significantly lower than those before surgery ().
(a)
(b)